MSHLX
Price
$52.76
Change
-$2.49 (-4.51%)
Updated
Nov 13 closing price
Net Assets
4.56B
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

MSHLX vs RGEBX

Header iconMSHLX vs RGEBX Comparison
Open Charts MSHLX vs RGEBXBanner chart's image
Morgan Stanley Inst Growth L
Price$52.76
Change-$2.49 (-4.51%)
VolumeN/A
Net Assets4.56B
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
MSHLX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
MSHLX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSHLX is a Hold and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. MSHLX (4.56B). MSHLX pays higher dividends than RGEBX: MSHLX (0.09) vs RGEBX (0.00). MSHLX was incepted earlier than RGEBX: MSHLX (14 years) vs RGEBX (11 years). MSHLX (1.37) is less costly to investors than RGEBX (1.09). MSHLX is a more actively managed with annual turnover of: 39.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSHLX: RGEBX (250) vs MSHLX (1000). MSHLX annual gain was more profitable for investors over the last year : 33.55 vs. RGEBX (8.10). RGEBX return over 5 years is better than : 36.65 vs. MSHLX (-26.61).
MSHLXRGEBXMSHLX / RGEBX
Total Expense Ratio1.371.09126%
Annual Report Gross Expense Ratio1.371.09126%
Fund Existence14 years11 years-
Gain YTD28.20219.219147%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.56B340B1%
Annual Yield % from dividends0.090.00-
Returns for 1 year33.558.10414%
Returns for 3 years98.3962.39158%
Returns for 5 years-26.6136.65-73%
Returns for 10 years40.9593.7844%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global